These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12202955)

  • 1. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C; Riggs BL; Khosla S
    Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of osteoclastogenesis and RANK expression by TGF-beta1.
    Yan T; Riggs BL; Boyle WJ; Khosla S
    J Cell Biochem; 2001 Aug 1-9; 83(2):320-5. PubMed ID: 11573248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF.
    Sells Galvin RJ; Gatlin CL; Horn JW; Fuson TR
    Biochem Biophys Res Commun; 1999 Nov; 265(1):233-9. PubMed ID: 10548519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures.
    Igarashi K; Hirotani H; Woo JT; Stern PH
    Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TGF-beta family in osteoclastogenesis induced by RANKL.
    Koseki T; Gao Y; Okahashi N; Murase Y; Tsujisawa T; Sato T; Yamato K; Nishihara T
    Cell Signal; 2002 Jan; 14(1):31-6. PubMed ID: 11747986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts.
    Kanno S; Hirano S; Kayama F
    Toxicology; 2004 Oct; 203(1-3):211-20. PubMed ID: 15363596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
    Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
    In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid multiparameter approach to study factors that regulate osteoclastogenesis: demonstration of the combinatorial dominant effects of TNF-alpha and TGF-ss in RANKL-mediated osteoclastogenesis.
    Huang W; Drissi MH; O'Keefe RJ; Schwarz EM
    Calcif Tissue Int; 2003 Dec; 73(6):584-93. PubMed ID: 14517717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
    Wittrant Y; Theoleyre S; Couillaud S; Dunstan C; Heymann D; Rédini F
    Exp Cell Res; 2004 Feb; 293(2):292-301. PubMed ID: 14729467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
    Asai K; Funaba M; Murakami M
    Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
    Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid-hormone-related protein induces expression of receptor activator of NF-{kappa}B ligand in human periodontal ligament cells via a cAMP/protein kinase A-independent pathway.
    Fukushima H; Jimi E; Kajiya H; Motokawa W; Okabe K
    J Dent Res; 2005 Apr; 84(4):329-34. PubMed ID: 15790738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
    Karsdal MA; Hjorth P; Henriksen K; Kirkegaard T; Nielsen KL; Lou H; Delaissé JM; Foged NT
    J Biol Chem; 2003 Nov; 278(45):44975-87. PubMed ID: 12933809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts.
    Otsuka E; Notoya M; Hagiwara H
    Calcif Tissue Int; 2003 Jul; 73(1):72-7. PubMed ID: 14506957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro.
    Cantley MD; Fairlie DP; Bartold PM; Rainsford KD; Le GT; Lucke AJ; Holding CA; Haynes DR
    J Cell Physiol; 2011 Dec; 226(12):3233-41. PubMed ID: 21344383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of calcitonin receptor by glucocorticoid in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
    Wada S; Yasuda S; Nagai T; Maeda T; Kitahama S; Suda S; Findlay DM; Iitaka M; Katayama S
    Endocrinology; 2001 Apr; 142(4):1471-8. PubMed ID: 11250927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
    Lee SK; Goldring SR; Lorenzo JA
    Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.